Links

Tools

Export citation

Search in Google Scholar

Large-scale genotyping identifies 41 new loci associated with breast cancer risk

Journal article published in 2013 by David van den Berg, Hereditary Breast Ovarian Canc Res, Breast Ovarian Canc Susceptibility, Marjanka K. Schmidt, Australian Ovarian Can Study Grp, Isabel Dos Santos Silva, R. B. Van Der Luijt, Qin Wang, Isabel dos Santos Silva, Clare Turnbull, Kyriaki Michailidou, Nazneen Rahman, Isabel dos Santos Silva, Per Hall, Anna Gonzalez-Neira and other authors.
This paper is available in a repository.
This paper is available in a repository.

Full text: Download

Question mark in circle
Preprint: policy unknown
Question mark in circle
Postprint: policy unknown
Question mark in circle
Published version: policy unknown

Abstract

Breast cancer is the most common cancer among women. Common variants at 27 loci have been identified as associated with susceptibility to breast cancer, and these account for ∼9% of the familial risk of the disease. We report here a meta-analysis of 9 genome-wide association studies, including 10,052 breast cancer cases and 12,575 controls of European ancestry, from which we selected 29,807 SNPs for further genotyping. These SNPs were genotyped in 45,290 cases and 41,880 controls of European ancestry from 41 studies in the Breast Cancer Association Consortium (BCAC). The SNPs were genotyped as part of a collaborative genotyping experiment involving four consortia (Collaborative Oncological Gene-environment Study, COGS) and used a custom Illumina iSelect genotyping array, iCOGS, comprising more than 200,000 SNPs. We identified SNPs at 41 new breast cancer susceptibility loci at genome-wide significance (P < 5 × 10(-8)). Further analyses suggest that more than 1,000 additional loci are involved in breast cancer susceptibility.